Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran. [electronic resource]
Producer: 20170328Description: 501-507 p. digitalISSN:- 1563-5279
- Adjuvants, Immunologic -- administration & dosage
- Aged
- Disability Evaluation
- Female
- Health Status
- Humans
- Injections, Subcutaneous
- Interferon beta-1a -- administration & dosage
- Iran
- Male
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Quality of Life -- psychology
- Retrospective Studies
- Severity of Illness Index
- Surveys and Questionnaires
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Observational Study
There are no comments on this title.
Log in to your account to post a comment.